Kamel Debbi, MD, PhD, is a radiation oncologist at Henri Mondor University Hospital, Assistance Publique-Hôpitaux de Paris, and Université Paris-Est Créteil, France. His clinical and research interests include prostate and breast cancer radiotherapy, advanced and complex radiation therapy techniques, as well as the safety and efficacy of combining radiotherapy with innovative systemic therapies. His research also focuses on radiobiology, particularly the role of the immune system in intrinsic radiosensitivity and in the identification of biomarkers predictive of response to radiotherapy. He is actively involved in clinical research, medical education, and the development of personalized radiation oncology approaches.
Disclosures:
- Employment: none
- Compensation: none
- Ownership: none
- Leadership: none